Endocannabinoid System RCT: Cannabis for Chronic Back Pain
The full-spectrum cannabis extract VER-01 back pain trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 randomized controlled study. Results showed significant pain reduction and good tolerability of VER-01 compared to placebo.…
Research Digest: 20 Recent Cannabis Studies – March 19, 2026
This recent cannabis research digest 2026 highlights 20 peer-reviewed studies curated for clinical relevance and evidence quality. The digest covers a range of topics including cannabinoid effects, clinical trials, and substance use disorders. Stay…
Cannabinoid Clinical Trials: EEG Insomnia Sleep RCT
This pilot trial studied acute effects of oral cannabinoids on sleep EEG in 20 adults with insomnia. A single dose of THC and CBD altered sleep architecture but did not improve total sleep time. These findings highlight important considerations for…
Cannabinoids for Pediatric Medicine: Clinical Evidence Review
Cannabinoids pediatric clinical evidence has been studied across many pediatric conditions. This review summarizes safety and efficacy data from hundreds of studies. Clinicians should carefully consider individual patient factors when evaluating…
PM Study Update: March 17, 2026 – Cannabis Clinical Trials
This PM Study Update covers 2026 cannabis clinical trials mental health research. It highlights important findings from recent clinical studies. The update provides valuable insights for clinicians and patients.
Cannabinoid Clinical Trials: Cannabis for Chronic Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract chronic low back pain treatment in 820 adults. Results showed significant pain reduction and sustained benefits. The full-spectrum cannabis extract chronic low back pain trial offers new…
Endocannabinoid System Clinical Research: 2024 RCT Review
This 2024 RCT review highlights digital mental health intervention cannabis research focusing on the Minder mobile app. The study evaluates its impact on university students' mental health and substance use. Digital tools like this are promising for…
CBD and Its Intrinsic Anti-Epileptic Properties: Clinical Trial Analysis
This CBD intrinsic anti epileptic properties trial found no measurable changes in cortical excitability or sedation from low or high doses in healthy volunteers. The study suggests CBD's anti-epileptic effects may depend on pharmacokinetic interactions…
AM Study Update: March 15, 2026
This AM Study Update presents cannabis clinical trials evidence from March 15, 2026, focusing on recent research findings. The report covers safety and efficacy data for various cannabis therapies. Clinicians can use this evidence to inform patient care…
Cannabinoid Clinical Trials: CBD & Cortical Excitability Insights
This clinical trial investigates CBD anti seizure properties and their impact on cortical excitability. Results suggest CBD alone does not significantly alter cortical excitability. The study emphasizes the role of pharmacokinetic interactions in seizure…